Yihong Li

Yihong Li has a strong background in scientific research, with experience spanning multiple companies. Their current role is as a Scientist at Eikon Therapeutics, a position they have held since March 2021. Prior to this, Yihong worked as a Scientist at R2M Pharma, Inc. from July 2018 to February 2021. They also have experience as a Senior Research Associate at Amgen from March 2006 to December 2014, and as a Senior Research Assistant at Eli Lilly & Co from March 2000 to March 2006. Yihong started their career as a Chemist at Abbott in November 1993 and worked there until March 2000.

Yihong Li obtained a Master of Science degree in Organic Chemistry from The University of Memphis, where they studied from 1990 to 1993. Before pursuing their master's degree, they completed their Bachelor's degree in Chemistry at Beijing Normal University. However, the specific start and end years for their studies at Beijing Normal University were not provided.